identified dynamic fluctuations in PD-L1 on CD4+/CD8+ T-cells around the partial mission phase of type 1 diabetes and suggested PD-L1 may be a potential target for prolonging this phase (85). This evidence concerns the gene CD274 and type 1 diabetes mellitus.